wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41290574-8969D32D-ECA4-467F-A144-A1E3B93B7B59
Q41290574-8969D32D-ECA4-467F-A144-A1E3B93B7B59
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41290574-8969D32D-ECA4-467F-A144-A1E3B93B7B59
Recent update on biological activities and pharmacological actions of liraglutide.
P2860
Q41290574-8969D32D-ECA4-467F-A144-A1E3B93B7B59
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41290574-8969D32D-ECA4-467F-A144-A1E3B93B7B59
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c1edf53ecfd7c6fa1a9afc7b54efb699435c90c9
P2860
Liraglutide Versus Lixisenatide: Long-Term Cost-Effectiveness of GLP-1 Receptor Agonist Therapy for the Treatment of Type 2 Diabetes in Spain